TOP TIERMARKET NEWSWIRE
News & sentiment

BRIDGEBIO PHARMA INC (BBIO) — News & AI sentiment

BRIDGEBIO PHARMA INC (BBIO) news roundup. 1 story in the past week, 21 over 30 days. Average 30-day sentiment is 54/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 10 sales totalling $37.9M — net selling of $37.9M. US House Periodic Transaction Reports (90-day window): 6 purchases (~$48K) and 0 sales (~$0). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 56/100
30d stories
21
avg sentiment 54/100
Insider net (90d)
$37.9M
0 buys · 10 sells
Congress (90d)
6
6 buys · 0 sells

Latest stories on BBIO

H.C. Wainwright reiterates BridgeBio Pharma stock rating on FDA filing
Investing.com Analyst Ratings56 · neutralanalyst
6d ago
Jul 22
BridgeBio Pharma, Inc. (BBIO) files 8-K
SEC 8-K50 · neutralgeneral
Jul 22
Jul 22
Jul 22
Jul 17
Jul 13
Jul 12
Jul 10
Jul 9
Jul 9
Jul 9
Jul 9
Jul 9
Jul 2
BridgeBio Pharma, Inc. (BBIO) files 8-K
SEC 8-K50 · neutralgeneral
Jul 2
Jul 2
BridgeBio secures up to $1B in preferred equity
Seeking Alpha24 · bearishgeneral
Jul 1
Jul 1
Jul 1
Jul 1
Jun 29
Jun 28
BridgeBio Pharma, Inc. (BBIO) files 8-K
SEC 8-K50 · neutralgeneral
Jun 26
Jun 23
Open BBIO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →